| Literature DB >> 34888392 |
Samuel S Rudisill1,2, Michael P Kucharik1, Nathan H Varady1,3, Scott D Martin1.
Abstract
BACKGROUND: Considering the lengthy recovery and high recurrence risk after a hamstring injury, effective rehabilitation and accurate prognosis are fundamental to timely and safe return to play (RTP) for athletes.Entities:
Keywords: hamstring injury; imaging; rehabilitation; return to play
Year: 2021 PMID: 34888392 PMCID: PMC8649106 DOI: 10.1177/23259671211053833
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Search Strategy
| MEDLINE (Ovid) |
|
Exp Hamstring muscles/ ((hamstring* or (biceps adj2 femoris) or semimembranosus or semitendinosus or thigh or (posterior adj2 thigh)) not ACL not cruciate).tw, kw 1 or 2 Exp “Wounds and Injuries”/ Exp “Sprains and Strains”/ Exp Pain/ (injur* or (leg adj2 injur*) or (sports adj2 injur*) or (athletic adj2 injur*) or strain* or sprain* or tear* or ruptur* or trauma* or pain* or dysfunction*).tw, kw 4 or 5 or 6 or 7 Exp Therapeutics/ Exp Rehabilitation/ Exp Diagnostic Imaging/ (therap* or rehab* or manag* or interven* or imag*).tw, kw 9 or 10 or 11 or 12 or 13 Exp “Recovery of Function”/ Exp Sports Medicine/ (recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participation” or “return to training” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participation” or “return-to-training”).tw, kw (re-occur* or recur* or reoccur* or re-inj* or reinj*).tw, kw 14 or 15 or 16 or 17 3 and 8 and 13 and 18 Limit 19 to (English language and full text) Limit 20 to MEDLINE |
|
|
|
(MH “hamstring muscles” OR MH thigh OR TI ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh))) OR AB ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh)))) NOT TI ACL NOT TI cruciate MH (“Wounds and Injuries”) OR MH (“Sprains and Strains”) OR MH “Pain” or TI ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) OR AB ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) MH Therapeutics OR MH Rehabilitation OR MH “Diagnostic Imaging” OR TI ((therap* or rehab* or manag* or interven* or imag*)) OR AB ((therap* or rehab* or manag* or interven* or imag*)) MH “Recovery of Function” OR MH “Sports Medicine” OR TI ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) OR AB ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) S1 AND S2 AND S3 AND S4 Narrow by language – English Limiters – full text |
|
|
|
(MH “hamstring muscles” OR MH thigh OR TI ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh))) OR AB ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh)))) NOT TI ACL NOT TI cruciate MH (“Wounds and Injuries”) OR MH (“Sprains and Strains”) OR MH “Pain” or TI ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) OR AB ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) MH Therapeutics OR MH Rehabilitation OR MH “Diagnostic Imaging” OR TI ((therap* or rehab* or manag* or interven* or imag*)) OR AB ((therap* or rehab* or manag* or interven* or imag*)) MH “Recovery of Function” OR MH “Sports Medicine” OR TI ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) OR AB ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) S1 AND S2 AND S3 AND S4 Narrow by language – English |
|
|
|
(MH “hamstring muscles” OR MH thigh OR TI ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh))) OR AB ((hamstring* or (biceps N2 femoris) or semimembranosus or semitendinosus or thigh or (posterior N2 thigh)))) NOT TI ACL NOT TI cruciate MH (“Wounds and Injuries”) OR MH (“Sprains and Strains”) OR MH “Pain” or TI ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) OR AB ((injur* or (leg N2 injur*) or (sports N2 injur*) or (athletic N2 injur*) or strain* or sprain* or tear* or rupture* or trauma* or pain* or dysfunction*)) MH Therapeutics OR MH Rehabilitation OR MH “Diagnostic Imaging” OR TI ((therap* or rehab* or manag* or interven* or imag*)) OR AB ((therap* or rehab* or manag* or interven* or imag*)) MH “Recovery of Function” OR MH “Sports Medicine” OR TI ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) OR AB ((recover* or progress* or convalescen* or outcome* or “return to play” or “return to sport” or “return to competition” or “return to participat*” or “return to train*” or “return-to-play” or “return-to-sport” or “return-to-competition” or “return-to-participat*” or “return-to-train*”)) S1 AND S2 AND S3 AND S4 Narrow by Language – English Limiters – Full Text |
Figure 1.Study flowchart.
Comparison of Patient Characteristics Between Studies of Proximal Versus Muscular Hamstring Injury
| Studies of Proximal Hamstring Injury Management | Studies of Muscular Hamstring Injury Management | |
|---|---|---|
| No. of patients | 775 | 1057 |
| Patient age, y, mean ± SD |
|
|
| Patient sex, % male |
|
|
Bold values were statistically significantly different between groups (P < .05).
Summary of Studies on Management of Acute Injuries to the Proximal Hamstring
| Additional Outcomes | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lead Author (Year) | Risk of Bias | Injury Type | Intervention | N | Mean ± SD Time to RTP, d | Reinjury Rate, % | Mean Follow-up, mo | Hamstring Strength | Hamstring ROM | H:Q Ratio | Functional Assessment |
| Arner (2019)
| 9 (16) | Partial proximal hamstring avulsion | Surgical | 64 | 333 (range, 150-1440) | — | 78 | X | |||
| Ayuob (2020)
| 12 (16) | Complete proximal semimembranosus rupture | Surgical | 20 | 83.3 ± 39.9 | 0.0 | 35 | X | X | X | |
| Ayuob (2020)
| 12 (16) | Partial/complete tear of proximal MTJ of long head of biceps | Surgical | 64 | 93.8 ± 35.7 | — | 24 | X | X | X | |
| Barnett (2015)
| 10 (16) | Partial/complete proximal hamstring avulsion | Surgical | 38 | — | — | 54 | X | |||
| Best (2019)
| 9 (16) | Complete proximal hamstring avulsion | Surgical | 49 | — | — | 28 | X | |||
| Biedert (2015)
| 9 (16) | Avulsion fracture of ischial tuberosity | Surgical | 3 | — | — | 24 | X | |||
| Birmingham (2011)
| 11 (16) | Complete proximal hamstring avulsion | Surgical | 23 | 294 (range, 90-1080) | — | 43 | X | X | ||
| Blakeney (2017)
| 15 (16) | Partial/complete proximal hamstring avulsion | Surgical | 96 | — | — | 34 | X | |||
| Bowman (2013)
| 10 (16) | Partial proximal hamstring avulsion | Surgical | 17 | — | — | 32 | X | |||
| Chahal (2012)
| 9 (16) | Complete proximal hamstring avulsion | Surgical | 13 | — | — | 24 | X | X | ||
| Hofmann (2014)
| 9 (16) | Complete proximal hamstring avulsion | Nonoperative | 17 | — | — | 31 | X | X | ||
| Klingele (2002)
| 10 (16) | Complete proximal hamstring avulsion | Surgical | 11 | 180 (range, 90-300) | — | 34 | X | |||
| Konan (2010)
| 12 (16) | Complete proximal hamstring avulsion | Surgical | 10 | 175 (range, 126-455) | — | 12 | X | X | ||
| Lefevre (2013)
| 18 (24) | Partial/complete proximal hamstring avulsion | Surgical | 34 | 171 ± 48 | — | 27 | X | X | X | |
| Léger-St-Jean (2019)
| 12 (16) | Complete proximal hamstring avulsion | Surgical | 22 | 120 (IQR, 60-240) | — | 6 | X | |||
| Lempainen (2006)
| 10 (16) | Partial proximal hamstring avulsion | Surgical | 48 | 150 (range, 30-360) | — | 36 | ||||
| Piposar (2017)
| 18 (24) | Partial/complete proximal hamstring avulsion | (1) Surgical | 15 | — | — | 30 | X | X | ||
| Sandmann (2016)
| 11 (16) | Complete proximal hamstring avulsion | Surgical | 16 | 180 (range, 120-270) | — | 56 | X | X | X | |
| Shambaugh (2017)
| 17 (24) | Complete proximal hamstring avulsion | (1) Surgical | 14 | — | — | 43 | X | X | ||
| Skaara (2013)
| 9 (16) | Partial proximal hamstring avulsion | Surgical | 31 | — | — | 30 | X | X | X | |
| Subbu (2014)
| 12 (16) | Complete proximal hamstring avulsion | Surgical | 78 | 112 (range, 84-224) | 0.0 | 24 | ||||
| Willinger (2020)
| 11 (16) | Partial/complete proximal hamstring avulsion | Surgical | 71 | — | — | 56 | X | |||
Dashes indicate data not reported. H:Q, hamstrings-to-quadriceps ratio; IQR, interquartile range; MTJ, myotendinous junction; ROM, range of motion; RTP, return to play; X, outcome(s) reported.
Reported as Methodological Index for Non-Randomized Studies score (maximum score).
Summary of Studies Managing Acute Injuries to Hamstring Muscle With Physiotherapy
| Additional Outcomes | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lead Author (Year) | Risk of Bias | Injury Type | Intervention(s) | N | Mean ± SD Time to RTP, d | Reinjury Rate, % | Mean Follow-up, d | Hamstring Strength | Hamstring ROM | H:Q Ratio | Functional Assessment |
| Albertin (2020)
| 10 (16) | Grade 2 | Primal Reflex Release Technique | 6 | — | — | — | X | X | ||
| Askling (2013)
| Some concerns | Sprinting or stretching | (1) L-protocol | 37 | 28 ± 15 | 0.0 | 12 | ||||
| Askling (2014)
| Some concerns | Sprinting or stretching | (1) L-protocol | 28 | 49 ± 26 | 0.0 | 12 | ||||
| Bayer (2018)
| Low | Munich type 3-4 | (1) Early rehab | 20 | 62.5 (IQR, 48.8-77.8) | 9.1 | 12 | X | X | ||
| Hickey (2020)
| Low | Grade 1-2 | (1) Pain-threshold rehab | 21 | 17 (95% CI, 11-24) | 9.5 | 6 | X | |||
| Kilcoyne (2011)
| 10 (16) | Grade 1-2 | Early, progressive rehab | 48 | 11.9 (range, 5-23) | 6.3 | 6 | ||||
| Kim (2018)
| Some concerns | Grade 2 | Stretching and ROM-based rehab | 13 | — | — | 2 | X | X | ||
| Kornberg (1989)
| Some concerns | Grade 1 | (1) Slump stretching | 12 | 1 absent >1 game | — | — | ||||
| Malliaropoulos (2004)
| Low | Grade 2 | (1) 1× daily stretching | 40 | 15.1 ± 0.8 | — | — | X | |||
| Medeiros (2020)
| Low | Grade 1-2 | (1) LLLT protocol | 11 | 23.1 ± 9.1 | 0.0 | 6 | X | X | ||
| Mendiguchia (2017)
| Low | Grade 1 | (1) Rehab algorithm | 24 | 25.5 ± 7.8 | 4.2 | 6 | ||||
| Sefiddhashti (2018)
| Some concerns | Grade 1-2 | (1) Cryotherapy with stretching | 18 | — | — | 0.25 | X | X | ||
| Sherry (2004)
| Low | Grade 1-2 | (1) STST protocol | 11 | 37.4 ± 27.6 | 70.0 | 12 | ||||
| Silder (2013)
| Low | Grade 1-2 | (1) PATS protocol | 13 | 28.8 ± 11.4 | 16.7 | 12 | X | |||
| Tyler (2017)
| 11 (16) | Grade 1-3 | Eccentric strength protocol | 50 | 77 ± 70 | 8.0 | 24 | X | |||
Dashes indicate data not reported. C-protocol, conventional protocol; H:Q, hamstrings-to-quadriceps ratio; IQR, interquartile range; L-protocol, lengthening protocol; LLLT, low-level laser therapy; PATS, progressive agility and trunk stabilization; PRES, progressive running and eccentric strengthening; rehab, rehabilitation; ROM, range of motion; RTP, return to play; STST, stretching and strengthening; X, outcome(s) reported.
Reported as Methodological Index for Non-Randomized Studies score (maximum score) for nonrandomized studies or Cochrane Risk-of-Bias Tool for Randomized Trials.
Significant difference between interventions (P < .001).
Significant difference between interventions (P < .05).
Summary of Studies Managing Acute Muscular Hamstring Injury Using PRP or Autologous Conditioned Serum
| Additional Outcomes | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Lead Author (Year) | Risk of Bias | Injury Type | Intervention | N | Mean ± SD Time to RTP, d | Reinjury Rate, % | Mean Follow-up, mo | Hamstring Strength | Hamstring ROM |
| A Hamid (2014)
| Low | Grade 1 | (1) PRP (1 × 3-mL direct injection 5 d postinjury | 14 | 26.7 ± 7.0 | — | — | X | |
| Bezuglov (2019)
| Low | BAMIC 2a/2b | (1) PRP (1 × 8-mL direct injection <48 h postinjury) | 20 | 11.4 ± 1.2 | 0.0 | 6 | ||
| Bradley (2020)
| 18 (24) | Cohen grade 2 | (1) PRP (1-3 × 2- to 5-mL direct injections 1 wk apart) | 30 | 22.5 ± 20.1 | 3.3 | — | ||
| Gaballah (2018)
| Low | Grade 2 | (1) PRP (1 × 3-mL direct injection, 5-7 d postinjury) | 8 | Maximum, 27 | — | — | X | |
| Guillodo (2015)
| 19 (24) | Grade 3 | (1) PRP (1 × 3-mL direct injection <8 d postinjury) | 15 | 50.9 ± 10.7 | — | — | ||
| Hamilton (2015)
| Low | Grade 1-2 | (1) PRP (3 × 1-mL injections 1 cm apart, <5 d postinjury) | 30 | 21 (95% CI, 18-24) | 7.7 | 6 | X | |
| Lee (2020)
| 12 (16) | Grade 1-3 | PRP (single injection) | 8 | 49 (range, 10-112) | — | — | ||
| Rettig (2013)
| 18 (24) | Grade 1-2 | (1) PRP (1 × 9-mL direct injection <48 h postinjury) | 5 | 20 (range, 16-30) | — | — | ||
| Reurink (2015)
| Low | Grade 1-2 | (1) PRP (3 × 1-mL injections 1 cm apart at 5 and 10 d postinjury) | 41 | 42 (IQR, 30-58) | 27.0 | 12 | X | X |
| Wright-Carpenter (2004)
| 19 (24) | Grade 2 | (1) Autologous conditioned serum (5 × 1-mL injections over area of injury every 2nd day [mean, 5.4 injections]) | 6 | 16.3 ± 3.1 | — | — | ||
| Zanon (2016)
| 12 (16) | Grade 2 | PRP (2-3 × 3-mL injections at 72 h and 7 d postinjury) | 25 | 35.1 ± 18.9 | 12.0 | 37 | ||
Dashes indicate data not reported. BAMIC, British Athletics Muscle Injury Classification; IQR, interquartile range; PPP, platelet-poor plasma; PRP, platelet-rich plasma; ROM, range of motion; RTP, return to play; X, outcome(s) reported.
Reported as Methodological Index for Non-Randomized Studies score (maximum score) for nonrandomized studies or Cochrane Risk-of-Bias Tool for Randomized Trials.
Significant difference between interventions (P < .05).
Summary of Studies Assessing Prognostic Value of Baseline Assessment
| Assessment | ||||
|---|---|---|---|---|
| Lead Author (Year) | Risk of Bias | N | Clinical | MRI |
| A Hamid (2014)
| Low | 28 | X | |
| A Hamid (2013)
| 10 (16) | 360 | X | |
| Askling (2006)
| 12 (16) | 33 | X | |
| Askling (2007)
| 14 (16) | 15 | X | X |
| Askling (2007)
| 14 (16) | 18 | X | X |
| Askling (2008)
| 11 (16) | 30 | X | X |
| Askling (2014)
| Some concerns | 56 | X | X |
| Askling (2013)
| Some concerns | 75 | X | X |
| Cohen (2011)
| 14 (16) | 38 | X | |
| Comin (2013)
| 20 (24) | 62 | X | |
| Crema (2018)
| 11 (16) | 22 | X | |
| Ekstrand (2012)
| 12 (16) | 207 | X | |
| Ekstrand (2016)
| 12 (16) | 255 | X | |
| Gibbs (2004)
| 12 (16) | 31 | X | |
| Guillodo (2014)
| 12 (16) | 128 | X | |
| Hallen (2014)
| 13 (16) | 386 | X | |
| Hamilton (2018)
| 13 (16) | 110 | X | |
| Jacobsen (2016)
| 14 (16) | 90 | X | X |
| Kilcoyne (2011)
| 10 (16) | 48 | X | |
| Malliaropoulos (2010)
| 21 (24) | 165 | X | |
| Moen (2014)
| 13 (16) | 74 | X | X |
| Pollock (2016)
| 11 (16) | 44 | X | |
| Pomeranz (1993)
| 10 (16) | 14 | X | |
| Schneider-Kolsky (2006)
| 21 (24) | 58 | X | X |
| Silder (2013)
| Low | 25 | X | |
| Slavotinek (2002)
| 12 (16) | 30 | X | |
| van der Made (2018)
| 14 (16) | 70 | X | |
| Verrall (2003)
| 12 (16) | 83 | X | X |
| Wangensteen (2015)
| 11 (16) | 180 | X | X |
| Warren (2010)
| 13 (16) | 59 | X | |
MRI, magnetic resonance imaging; X, outcome(s) reported.
Reported as Methodological Index for Non-Randomized Studies score (maximum score) for nonrandomized studies or Cochrane Risk-of-Bias Tool for Randomized Trials.
Baseline Assessment Findings and Prognostic Relationships With RTP Times
| Clinical Factors | MRI Factors |
|---|---|
| RTP Prognosis: Accelerated | |
| Pain during outer-range strength test
| BAMIC grade 0
|
| Midrange strength as % of uninjured leg
| Shorter radiologist-predicted time to RTP
|
| SLR flexibility of uninjured leg
| Shorter length of lesion
|
| Greater physiotherapy attendance
| Smaller injury CSA
|
| Shorter clinician-predicted time to RTP
| MRI-negative injury
|
| Lower grade of injury
| Single muscle/tendon involvement
|
| Sprinting-type vs stretching-type injury
| Lower % of muscle/tendon involvement
|
| Lower radiologic grade of injury
| |
| Lower Cohen MRI score
| |
| Injuries not involving proximal tendon
| |
| RTP Prognosis: No Effect | |
| Sex
| Craniocaudal length of injury
|
| Dominant vs nondominant limb
| Mediolateral width of injury
|
| Sudden vs gradual pain onset
| Depth of injury
|
| Injury during game vs training
| Volume of edema
|
| Forced to cease activity within 5 min
| Tendon involvement
|
| Ability to walk/jog pain-free
| Myofascial involvement
|
| No. of days to walk pain-free
| Muscle (most) involved
|
| No. of days to ascend stairs pain-free
| Injury CSA as % of total muscle CSA
|
| Mechanism of injury
| Distance of injury from ischium
|
| History of low back pain
| Intra- or intermuscular hemorrhage
|
| History of lower limb injury
| Site of injury within the muscle
|
| History of lower limb surgery
| Grade 1 vs grade 2 injury
|
| Pain on 1- or 2-leg squat
| MRI grade of injury
|
| Pain on palpation of injured area
| Presence of extramuscular fluid
|
| Craniocaudal length of palpated pain
| Partial disruption of the central tendon
|
| Mediolateral width of palpated pain
| Amount of central tendon retraction
|
| Distance of palpated pain from ischium
| BAMIC type a vs b
|
| Location of point of highest palpated pain
| |
| Site of injury within the muscle
| |
| No. of muscles injured
| |
| Positive vs negative slump test
| |
| Frequency of physiotherapy
| |
| Grade of injury
| |
| Level of play/intensity of sport
| |
| Delay in seeking physiotherapy
| |
| Active knee extension deficit
| |
| Pain upon active knee extension
| |
| Pain upon PKE
| |
| Pain on passive SLR
| |
| Pain upon isometric contraction
| |
| Previous ACL graft harvesting
| |
| Isometric knee flexion strength
| |
| Hip ROM
| |
| Use of NSAIDs within 72 h of injury
| |
| RTP Prognosis: Delayed | |
| Female sex
| Volume of injury
|
| Greater PKE range of uninjured leg
| Greater craniocaudal length of injury
|
| Greater peak torque angle in knee extension
| Greater width of edema
|
| Higher grade of injury
| Greater length of lesion as % of height
|
| Injury to biceps femoris
| Greater depth of injury
|
| Shorter distance of pain to ischium
| Longer radiologist-predicted time to RTP
|
| Stretching-type vs sprinting-type injury
| Larger injury CSA
|
| Greater maximum pain at time of injury
| Involvement of proximal tendon
|
| Worst VAS pain score >6
| Proximal vs distal injuries
|
| Higher VAS pain score at initial examination
| Shorter distance of injury to ischium
|
| “Popping” sound at time of injury
| Higher Cohen MRI score
|
| Bruising
| MRI-positive injury
|
| Greater deficit in passive SLR
| Greater % of muscle/tendon involvement
|
| Longer clinician-predicted time to RTP
| Complete tendinous/myotendinous rupture
|
| Forced to cease activity within 5 min
| Complete central tendon disruption
|
| Greater length of palpated pain
| Presence of central tendon waviness
|
| Pain on resisted knee flexion
| Greater central tendon retraction
|
| >1 wk to initial consultation
| Higher radiologic grade of injury
|
| Recurrent muscle injury
| Greater No. of muscles involved
|
| Greater active knee ROM deficit
| Distal tendinous or myotendinous injury
|
| Longer self-predicted time to RTP
| Peritendinous fluid collection
|
| Lower level of sport
| |
| >1 d to walk pain-free
| |
ACL, anterior cruciate ligament; BAMIC, British Athletics Muscle Injury Classification; CSA, cross-sectional area; MRI, magnetic resonance imaging; NSAID, nonsteroidal anti-inflammatory drug; PKE, passive knee extension; ROM, range of motion; RTP, return to play; SLR, straight-leg raise; VAS, visual analog scale.